The US Centers for Medicare & Medicaid Services is once again backing off a proposal that would have changed the “protected” status of some classes of medicines in the Part D prescription drug benefit.
On March 16, the agency told Part D sponsors that it would not, after all, be making any changes to a demonstration project that tests a different risk sharing formula...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?